Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New GSK-3beta inhibitors and their use in Alzheimer's disease and other disorders

Oct. 29, 2004

New alpha2delta-selective calcium channel ligands discovered at Pfizer

Oct. 29, 2004

Encysive scientists design new urotensin II antagonists

Oct. 29, 2004

New antirotavirus agents prepared and tested at ViroPharma

Oct. 29, 2004

Guilford researchers present novel NAALADase inhibitors

Oct. 29, 2004

Novel antibacterial methionyl tRNA synthetase inhibitors claimed by Replidyne

Oct. 29, 2004

Vertex describes Na+ and/or Ca2+ channel blockers for pain and other uses

Oct. 28, 2004

New ALK5 inhibitors covered by Pfizer patent

Oct. 28, 2004

Novel TNF-alpha and IL-1 production inhibitors discovered at Pliva

Oct. 28, 2004

Santhera claims new calpain inhibitors for muscular dystrophy and other uses

Oct. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...